Log In
BCIQ
Print this Print this
 

SEL212

  Manage Alerts
Collapse Summary General Information
Company Selvita S.A.
DescriptionSmall molecule modulator of NLR family pyrin domain containing 3 (NLRP3; NALP3) inflammasome
Molecular Target NLR family pyrin domain containing 3 (NLRP3) (NALP3) (CIAS1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune disorders
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today